Antikoagulācijas ārstēšana un novēršana

Strategies to prevent blood loss and reduce transfusion in emergency general surgery, WSES-AAST consensus paper. (opens new window)

Coccolini F, Shander A, Ceresoli M, Moore E, Tian B, Parini D, Sartelli M, Sakakushev B, Doklestich K, Abu-Zidan F, Horer T, Shelat V, Hardcastle T, Bignami E, Kirkpatrick A, Weber D, Kryvoruchko I, Leppaniemi A, Tan E, Kessel B, Isik A, Cremonini C, Forfori F, Ghiadoni L, Chiarugi M, Ball C, Ottolino P, Hecker A, Mariani D, Melai E, Malbrain M, Agostini V, Podda M, Picetti E, Kluger Y, Rizoli S, Litvin A, Maier R, Beka SG, De Simone B, Bala M, Perez AM, Ordonez C, Bodnaruk Z, Cui Y, Calatayud AP, de Angelis N, Amico F, Pikoulis E, Damaskos D, Coimbra R, Chirica M, Biffl WL, Catena F

Avots‎: World J Emerg Surg 2024;19(1):26.

Raksts indeksēts‎: PubMed 39010099

DOI‎: 10.1186/s13017-024-00554-7

https://pubmed.ncbi.nlm.nih.gov/39010099/ (opens new window)

Four-factor prothrombin complex concentrate versus plasma for rapid vitamin K antagonist reversal in patients needing urgent surgical or invasive interventions: a phase 3b, open-label, non-inferiority, randomised trial. (opens new window)

Goldstein JN, Refaai MA, Milling TJ Jr, Lewis B, Goldberg-Alberts R, Hug BA, Sarode R.

Avots‎: Lancet 2015;385(9982):2077-87.

Raksts indeksēts‎: PubMed 25728933

DOI‎: 10.1016/S0140-6736(14)61685-8

https://www.ncbi.nlm.nih.gov/pubmed/25728933 (opens new window)

Guidance on the emergent reversal of oral thrombin and factor Xa inhibitors. (opens new window)

Kaatz S, Kouides PA, Garcia DA, Spyropolous AC, Crowther M, Douketis JD, Chan AK, James A, Moll S, Ortel TL, Van Cott EM, Ansell J.

Avots‎: Am J Hematol 2012;87 Suppl 1:S141-5.

Raksts indeksēts‎: PubMed 22473649

DOI‎: 10.1002/ajh.23202

https://www.ncbi.nlm.nih.gov/pubmed/22473649 (opens new window)

Bleeding risk and reversal strategies for old and new anticoagulants and antiplatelet agents. (opens new window)

Levi M, Eerenberg E, Kamphuisen PW.

Avots‎: J Thromb Haemost 2011;9(9):1705-12.

Raksts indeksēts‎: PubMed 21729240

DOI‎: 10.1111/j.1538-7836.2011.04432.x

https://www.ncbi.nlm.nih.gov/pubmed/21729240 (opens new window)

Emergency reversal of warfarin anticoagulation. (opens new window)

Lin Y, Callum J.

Avots‎: CMAJ 2010;182(18):2004.

Raksts indeksēts‎: PubMed 21078740

DOI‎: 10.1503/cmaj.100983

https://www.ncbi.nlm.nih.gov/pubmed/21078740 (opens new window)

Management of anticoagulation agents in trauma patients. (opens new window)

McCoy CC, Lawson JH, Shapiro ML.

Avots‎: Clin Lab Med 2014;34(3):563-74.

Raksts indeksēts‎: PubMed 25168942

DOI‎: 10.1016/j.cll.2014.06.013

https://www.ncbi.nlm.nih.gov/pubmed/25168942 (opens new window)

Idarucizumab for dabigatran reversal - full cohort analysis. (opens new window)

Pollack CV Jr, Reilly PA, van Ryn J, Eikelboom JW, Glund S, Bernstein RA, Dubiel R, Huisman MV, Hylek EM, Kam CW, Kamphuisen PW, Kreuzer J, Levy JH, Royle G, Sellke FW, Stangier J, Steiner T, Verhamme P, Wang B, Young L, Weitz JI

Avots‎: N Engl J Med 2017;377(5):431-41.

Raksts indeksēts‎: PubMed 28693366

DOI‎: 10.1056/NEJMoa1707278

https://www.ncbi.nlm.nih.gov/pubmed/28693366 (opens new window)

Reversal of clopidogrel-induced bleeding with rFVIIa in healthy subjects: a randomized, placebo-controlled, double-blind, exploratory study. (opens new window)

Skolnick BE, Shenouda M, Khutoryansky NM, Pusateri AE, Gabriel D, Carr ME.

Avots‎: Anesth Analg 2011;113(4):703-10.

Raksts indeksēts‎: PubMed 21890888

DOI‎: 10.1213/ANE.0b013e318228c690

https://www.ncbi.nlm.nih.gov/pubmed/21890888 (opens new window)

Rapid warfarin reversal in the setting of intracranial hemorrhage: a comparison of plasma, recombinant activated factor VII, and prothrombin complex concentrate. (opens new window)

Woo CH, Patel N, Conell C, Rao VA, Faigeles BS, Patel MC, Pombra J, Akins PT, Axelrod YK, Ge IY, Sheridan WF, Flint AC.

Avots‎: World Neurosurg 2014;81(1):110-5.

Raksts indeksēts‎: PubMed 23220122

DOI‎: 10.1016/j.wneu.2012.12.002

https://www.ncbi.nlm.nih.gov/pubmed/23220122 (opens new window)

TRAUMAS UN NEATLIEKAMĀ MEDICĪNISKĀ PALĪDZĪBA

Antikoagulācijas ārstēšana un novēršana

latviešu

Antikoagulācijas ārstēšana un novēršana

/assets/ct/37b1eeb581/images/syn_placeholder_sqr.png

Strategies to prevent blood loss and reduce transfusion in emergency general surgery, WSES-AAST consensus paper. (opens new window)

Four-factor prothrombin complex concentrate versus plasma for rapid vitamin K antagonist reversal in patients needing urgent surgical or invasive interventions: a phase 3b, open-label, non-inferiority, randomised trial. (opens new window)

Guidance on the emergent reversal of oral thrombin and factor Xa inhibitors. (opens new window)

Bleeding risk and reversal strategies for old and new anticoagulants and antiplatelet agents. (opens new window)

Emergency reversal of warfarin anticoagulation. (opens new window)

Management of anticoagulation agents in trauma patients. (opens new window)

Idarucizumab for dabigatran reversal - full cohort analysis. (opens new window)

Reversal of clopidogrel-induced bleeding with rFVIIa in healthy subjects: a randomized, placebo-controlled, double-blind, exploratory study. (opens new window)

Rapid warfarin reversal in the setting of intracranial hemorrhage: a comparison of plasma, recombinant activated factor VII, and prothrombin complex concentrate. (opens new window)

Vietējā komiteja saziņai ar slimnīcām (KSS)

Informatīvi medicīnisko materiālu komplekti

Video

Antikoagulācijas ārstēšana un novēršana

Izvēlieties valodu